FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200531306> ?p ?o ?g. }

• W4200531306 endingPage "13" @default.
• W4200531306 startingPage "7" @default.
• W4200531306 abstract "A previously published, single-institution, case series suggested an association between topiramate administration in neonates and subsequent development of necrotizing enterocolitis (NEC). This contradicted our more extensive experiences using topiramate in this population. We therefore studied safety and tolerability of topiramate for treating refractory neonatal seizures, hypothesizing that the risk of developing NEC following topiramate exposure was low and that most infants tolerate topiramate.This multicenter retrospective cohort study included seventy-five neonates who received topiramate to treat seizures from January 2011 to October 2019 at three geographically diverse level IV neonatal intensive care units affiliated with pediatric tertiary hospitals. Data included demographics, birth history, seizure etiology, treatment response, side effects, and occurrence and details of NEC.Three of seventy-five infants (4%) developed NEC following topiramate exposure. These infants did not differ in gestational age, birth weight, seizure etiology, postmenstrual age, weight when topiramate was initiated, or dosing of topiramate. Topiramate was well tolerated. Only three infants (4%) discontinued due to side effects. The most common side effect (20%) was weight loss (typically <5%). Topiramate was felt to be efficacious (61%). Most infants (72%) continued topiramate when discharged.Our multicenter, 75-infant study demonstrated that development of NEC after treatment with topiramate was rare (4%) and refutes prior literature suggesting an association. Topiramate was felt to be efficacious and was well tolerated. Although limited by retrospective design, study data are broadly applicable and support thoughtful use of topiramate as a safe, reasonable option for treating refractory neonatal seizures." @default.
• W4200531306 created "2021-12-31" @default.
• W4200531306 creator A5004620650 @default.
• W4200531306 creator A5008823765 @default.
• W4200531306 creator A5030192261 @default.
• W4200531306 creator A5036009607 @default.
• W4200531306 creator A5064931499 @default.
• W4200531306 creator A5066122769 @default.
• W4200531306 date "2022-04-01" @default.
• W4200531306 modified "2023-10-16" @default.
• W4200531306 title "Topiramate Is Safe for Refractory Neonatal Seizures: A Multicenter Retrospective Cohort Study of Necrotizing Enterocolitis Risk" @default.
• W4200531306 cites W1596368460 @default.
• W4200531306 cites W1710490174 @default.
• W4200531306 cites W1856132450 @default.
• W4200531306 cites W1985848675 @default.
• W4200531306 cites W1996095362 @default.
• W4200531306 cites W1996172050 @default.
• W4200531306 cites W2011115491 @default.
• W4200531306 cites W2053288742 @default.
• W4200531306 cites W2078160553 @default.
• W4200531306 cites W2084931732 @default.
• W4200531306 cites W2093274439 @default.
• W4200531306 cites W2099644688 @default.
• W4200531306 cites W2103487664 @default.
• W4200531306 cites W2142300947 @default.
• W4200531306 cites W2290227042 @default.
• W4200531306 cites W2338386685 @default.
• W4200531306 cites W2737342031 @default.
• W4200531306 cites W2773340849 @default.
• W4200531306 cites W2808001652 @default.
• W4200531306 cites W2944434778 @default.
• W4200531306 cites W2946468377 @default.
• W4200531306 cites W4235469056 @default.
• W4200531306 doi "https://doi.org/10.1016/j.pediatrneurol.2021.12.003" @default.
• W4200531306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35131568" @default.
• W4200531306 hasPublicationYear "2022" @default.
• W4200531306 type Work @default.
• W4200531306 citedByCount "3" @default.
• W4200531306 countsByYear W42005313062022 @default.
• W4200531306 countsByYear W42005313062023 @default.
• W4200531306 crossrefType "journal-article" @default.
• W4200531306 hasAuthorship W4200531306A5004620650 @default.
• W4200531306 hasAuthorship W4200531306A5008823765 @default.
• W4200531306 hasAuthorship W4200531306A5030192261 @default.
• W4200531306 hasAuthorship W4200531306A5036009607 @default.
• W4200531306 hasAuthorship W4200531306A5064931499 @default.
• W4200531306 hasAuthorship W4200531306A5066122769 @default.
• W4200531306 hasConcept C118552586 @default.
• W4200531306 hasConcept C121332964 @default.
• W4200531306 hasConcept C126322002 @default.
• W4200531306 hasConcept C141071460 @default.
• W4200531306 hasConcept C142424586 @default.
• W4200531306 hasConcept C167135981 @default.
• W4200531306 hasConcept C187212893 @default.
• W4200531306 hasConcept C197934379 @default.
• W4200531306 hasConcept C2777683783 @default.
• W4200531306 hasConcept C2778186239 @default.
• W4200531306 hasConcept C2778375690 @default.
• W4200531306 hasConcept C2778376644 @default.
• W4200531306 hasConcept C2779234561 @default.
• W4200531306 hasConcept C2779303187 @default.
• W4200531306 hasConcept C42219234 @default.
• W4200531306 hasConcept C54355233 @default.
• W4200531306 hasConcept C71924100 @default.
• W4200531306 hasConcept C86803240 @default.
• W4200531306 hasConcept C87355193 @default.
• W4200531306 hasConceptScore W4200531306C118552586 @default.
• W4200531306 hasConceptScore W4200531306C121332964 @default.
• W4200531306 hasConceptScore W4200531306C126322002 @default.
• W4200531306 hasConceptScore W4200531306C141071460 @default.
• W4200531306 hasConceptScore W4200531306C142424586 @default.
• W4200531306 hasConceptScore W4200531306C167135981 @default.
• W4200531306 hasConceptScore W4200531306C187212893 @default.
• W4200531306 hasConceptScore W4200531306C197934379 @default.
• W4200531306 hasConceptScore W4200531306C2777683783 @default.
• W4200531306 hasConceptScore W4200531306C2778186239 @default.
• W4200531306 hasConceptScore W4200531306C2778375690 @default.
• W4200531306 hasConceptScore W4200531306C2778376644 @default.
• W4200531306 hasConceptScore W4200531306C2779234561 @default.
• W4200531306 hasConceptScore W4200531306C2779303187 @default.
• W4200531306 hasConceptScore W4200531306C42219234 @default.
• W4200531306 hasConceptScore W4200531306C54355233 @default.
• W4200531306 hasConceptScore W4200531306C71924100 @default.
• W4200531306 hasConceptScore W4200531306C86803240 @default.
• W4200531306 hasConceptScore W4200531306C87355193 @default.
• W4200531306 hasLocation W42005313061 @default.
• W4200531306 hasLocation W42005313062 @default.
• W4200531306 hasOpenAccess W4200531306 @default.
• W4200531306 hasPrimaryLocation W42005313061 @default.
• W4200531306 hasRelatedWork W1968550933 @default.
• W4200531306 hasRelatedWork W2105422910 @default.
• W4200531306 hasRelatedWork W2116958051 @default.
• W4200531306 hasRelatedWork W2172275204 @default.
• W4200531306 hasRelatedWork W2331350967 @default.
• W4200531306 hasRelatedWork W2373597686 @default.
• W4200531306 hasRelatedWork W2378369323 @default.
• W4200531306 hasRelatedWork W2561160340 @default.
• W4200531306 hasRelatedWork W2808001652 @default.

• next